News

Alvotech: A Fast-Expanding Biosimilar Concern
Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt ...
Zacks Investment Research on MSN3d
TEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock?
Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has ...
Contract Pharma4d
Alvotech Names Chief Financial Officer
Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
Linda Jónsdóttir Linda Jonsdottir, Alvotech's new Chief Financial Officer REYKJAVIK, ICELAND (July 10, 2025) — Alvotech ...
Alvotech expands biosimilars capabilities with Ivers-Lee acquisition
Ivers-Lee’s assembly and packaging capabilities will be integrated into Alvotech's Technical Operations division.
Why Is Alvotech Stock Trading Higher On Wednesday?
Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.
Alvotech acquires Ivers-Lee Group
Alvotech ( NASDAQ: ALVO) is expanding its capacity for assembly and packaging with the acquisition of Ivers-Lee Group. Based in Burgdorf, Switzerland, Ivers-Lee provides assembly and packaging ...
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...